IRIS
BOLIGNANO, DAVIDE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.038
EU - Europa 1.623
AS - Asia 661
SA - Sud America 445
AF - Africa 22
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.790
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.021
SE - Svezia 535
IE - Irlanda 489
BR - Brasile 416
CN - Cina 277
SG - Singapore 268
DE - Germania 155
UA - Ucraina 122
FI - Finlandia 94
IT - Italia 73
GB - Regno Unito 57
FR - Francia 36
HK - Hong Kong 28
IN - India 26
CZ - Repubblica Ceca 12
BE - Belgio 11
RU - Federazione Russa 11
AR - Argentina 10
AT - Austria 9
MA - Marocco 8
TR - Turchia 8
BD - Bangladesh 7
IQ - Iraq 7
EC - Ecuador 6
CA - Canada 5
LV - Lettonia 5
TN - Tunisia 5
VE - Venezuela 5
AZ - Azerbaigian 4
UZ - Uzbekistan 4
CH - Svizzera 3
CO - Colombia 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
MX - Messico 3
NP - Nepal 3
PS - Palestinian Territory 3
UY - Uruguay 3
ZA - Sudafrica 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
BH - Bahrain 2
BN - Brunei Darussalam 2
EG - Egitto 2
HN - Honduras 2
ID - Indonesia 2
IR - Iran 2
JP - Giappone 2
OM - Oman 2
PK - Pakistan 2
SN - Senegal 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
AO - Angola 1
BO - Bolivia 1
CR - Costa Rica 1
CY - Cipro 1
GT - Guatemala 1
HU - Ungheria 1
JO - Giordania 1
KE - Kenya 1
KG - Kirghizistan 1
KW - Kuwait 1
KZ - Kazakistan 1
LB - Libano 1
LT - Lituania 1
NI - Nicaragua 1
NL - Olanda 1
NO - Norvegia 1
PA - Panama 1
PL - Polonia 1
PY - Paraguay 1
RO - Romania 1
SA - Arabia Saudita 1
TW - Taiwan 1
VN - Vietnam 1
Totale 4.790
Salva come PNG Salva come JPEG
Città #
Chandler 499
Dublin 489
Jacksonville 282
Nyköping 251
Singapore 157
Beijing 120
Ashburn 97
Dearborn 90
Princeton 73
The Dalles 72
Cambridge 69
Medford 64
Des Moines 56
Ann Arbor 50
Boardman 50
New York 35
Hong Kong 28
Helsinki 26
Bremen 25
Los Angeles 25
Lancaster 22
São Paulo 21
San Mateo 20
Munich 19
Woodbridge 19
Jinan 18
Wilmington 16
Pune 13
Belo Horizonte 12
Nanjing 12
Seattle 12
Brussels 11
Düsseldorf 11
Shenyang 10
Brasília 9
Curitiba 9
Haikou 9
Hebei 9
Ningbo 9
Augusta 8
Brno 8
Frankfurt am Main 8
Houston 8
Falls Church 7
Hyderabad 7
Nanchang 7
Porto Alegre 7
Rio de Janeiro 7
Tappahannock 7
Lauterbourg 6
Leawood 6
Campinas 5
Dhaka 5
Jiaxing 5
Norwalk 5
Portsmouth 5
Riga 5
Tianjin 5
Washington 5
Zhengzhou 5
Baku 4
Carapicuíba 4
Contagem 4
Goiânia 4
Guangzhou 4
Hangzhou 4
Manaus 4
Recife 4
Santa Clara 4
Tashkent 4
Uberaba 4
Vienna 4
Campos dos Goytacazes 3
Caraguatatuba 3
Clearwater 3
Council Bluffs 3
Duque de Caxias 3
Foggia 3
Guarulhos 3
Istanbul 3
Lanzhou 3
Lentini 3
Licata 3
Londrina 3
Nova Iguaçu 3
Olomouc 3
Ribeirão Preto 3
Rio Grande 3
Rome 3
Salvador 3
Shanghai 3
Stockholm 3
Taiyuan 3
Taizhou 3
Torres 3
Viamão 3
Vitória da Conquista 3
Araçatuba 2
Baghdad 2
Bandar Seri Begawan 2
Totale 3.079
Salva come PNG Salva come JPEG
Nome #
Both IL-1β and TNF-α Regulate NGALExpression in Polymorphonuclear Granulocytes ofChronic Hemodialysis Patients 105
Dialysis and the Elderly: An Underestimated Problem. 95
Neutrophilgelatinase-associatedlipocalin(NGAL); un biomarker oltre i confini della nefrologia 93
Cold pressor test stimulates the mobilization of endothelial progenitor cells in hypertensive and uremic patients 89
A brief "update" on renal effects of caffeine 86
Effect of immunoglobulin treatment on endothelial progenitor cells in systemic lupus erythematosus 85
Caffeine and the kidney: What evidence right now? 84
A new therapy for kidney injury: regeneration. 84
Down with the erythropoietin. Long live the erythropoietin! 83
Aquaretic inhibits renal cancer proliferation: Role of vasopressin receptor-2 (V2-R). 82
Urinary neutrophil gelatinase-associated lipocalin (uNGAL) levels in patients with Crohn’s disease undergoing treatment with infliximab. 81
Alterations of lipid metabolism in chronic nephropathies: mechanisms, diagnosis and treatment. 81
Neutrophil gelatinase-associated lipocalin serum evaluation through normal pregnancy and in pregnancies complicated by preeclampsia. 80
The erythropoietin and regenerative medicine: a lesson from fish 79
Effects of haemodialysis on circulating endothelial progenitor cell count 78
Aquaretic agents: What's beyond the treatment of hyponatremia? 77
Circulating endothelial progenitor cell mobilization in centenarians: a powerful source for extended renal life. 77
Neurobiological model and quality of life in discovering personality of the uremic patient. 76
Renal complications in oncohematologic patients. 76
Therapy with vasopressin receptor antagonists: the aquaretics 76
Acute cardiovascular complications of hemodialysis. 75
Circulating progenitor cells after cold pressor test in hypertensive and uremic patients 74
Experimental therapies in renal replacement: The effect of two different potassium acetate-free biofiltration protocols on striated muscle fibers 74
[Erythropoietin: pleiotropic actions]. 73
Arrhythmias and hemodialysis: role of potassium and new diagnostic tools. 73
Aquaporin-2 (AQP2) urinary excretion and assumption of water with different mineral content in healthy subjects 73
A case-by-case protocol of membranous nephropathy treatment with endovenous infusion of high doses of human immunoglobulins 72
Aquaretic-induced apoptosis: a cure or a curse? 71
Neutrophil gelatinase-associated lipocalin (NGAL): a new piece of the anemia puzzle? 71
Antioxidant agents for delaying diabetic kidney disease progression: A systematic review and meta-analysis 71
Xanthine oxidase inhibitors for improving renal function in chronic kidney disease patients: An updated systematic review and meta-analysis 71
Genomic damage in endothelial progenitor cells from uremic patients in hemodialysis 70
Neutrophil gelatinase-associated lipocalin (NGAL) reflects iron status in haemodialysis patients 70
Malnutrition in the elderly patient on dialysis. 70
Neutrophil gelatinase-associated lipocalin (NGAL) in human neoplasias: a new protein enters the scene. 70
From the oxygen to the organ protection: erythropoietin as protagonist in internal medicine 70
Neutrophil gelatinase-associated lipocalin (NGAL) as a marker of kidney damage 67
Perioperative iloprost and endothelial progenitor cells in uremic patients with severe limb ischemia undergoing peripheral revascularization. 67
Relaxin: New Pathophysiological Aspects and Pharmacological Perspectives for an Old Protein. 65
Erythropoietin and its lost receptor [8] 65
Pregnancy in uremic patients: An eventful journey 64
Pathological and prognostic value of urinary neutrophil gelatinase-associated lipocalin in macroproteinuric patients with worsening renal function 64
Neutrophil Gelatinase-Associated Lipocalin (NGAL) and progression of chronic kidney disease. 64
Neutrophil gelatinase-associated lipocalin as an early biomarker of nephropathy in diabetic patients. 64
Levels of neutrophil gelatinase-associated lipocalin in 2 patients with crush syndrome after a mudslide. 64
Neutrophil gelatinase-associated lipocalin reflects the severity of renal impairment in subjects affected by chronic kidney disease 63
Erythropoietin and cancer: an old risk. 63
Erythropoietin and its lost receptor. 63
Regenerative medicine: does Erythropoietin have a role? 62
Il Cold Pressor Test stimola la mobilizzazione di cellule staminali ad indirizzo endoteliale nei soggetti ipertesi ed uremici 59
Neutrophil gelatinase-associated lipocalin in patients with autosomal-dominant polycystic kidney disease. 57
Obestatin: a new element for mineral metabolism and inflammation in patients on hemodialysis. 57
RAS inhibition modulates kynurenine levels in a CKD population with and without type 2 diabetes mellitus 57
Pulmonary hypertension and erythropoietin. 56
Parathyroid hormone and mobilization of circulating bone marrow-derived cells in uremic patients. 56
Neutrophil gelatinase-associated lipocalin immunoexpression in renal tumors: correlation with histotype and histological grade. 55
Modifications in relaxin's serum levels during acetate-free biofiltration (AFB): only a new biomarker? 55
Antiproteinuric effect of DPP-IV inhibitors in diabetic and non-diabetic kidney diseases 55
Genomic damage in endothelial progenitor cells from uremic patients. 52
Endothelial progenitor cells: pathogenetic role and therapeutic perspectives 52
NGAL is a precocious marker of therapeutic response. 50
Exploring the effects of DPP-4 inhibitors on the kidney from the bench to clinical trials 48
Endothelial progenitor cells at the interface of chronic kidney disease: from biology to therapeutic advancement 46
From kidney to cardiovascular diseases: NGAL as a biomarker beyond the confines of nephrology. 44
Osteoprotegerin and carotid atherosclerosis in dialysis patients: An imaging (ECO-Doppler) and genic expression study 43
Neutrophil gelatinase-associated lipocalin levels in chronic haemodialysis patients. 43
NGAL: a new missing link between inflammation and uremic anemia? 41
null 39
Neutrophil gelatinase-associated lipocalin in the intensive care unit: time to look beyond a single, threshold-based measurement? 38
Parathyroid hormone variability parameters for identifying high turnover osteodystrophy disease in hemodialysis patients: An observational retrospective cohort study 37
Preeclampsia and cardiovascular risk: general characteristics, counseling and follow-up. 32
null 30
Renal Concerns in the Treatment of Chronic Hepatitis B with Tenofovir 27
Neutrophil gelatinase-associated lipocalin levels in patients with crohn disease undergoing treatment with infliximab. 23
null 16
Increased plasma neutrophil gelatinase-associated lipocalin levels predict mortality in elderly patients with chronic heart failure. 9
Totale 4.827
Salva come PNG Salva come JPEG
Categoria #
all - tutte 21.118
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.118
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202080 0 0 0 0 0 0 0 0 0 0 76 4
2020/2021408 63 4 69 33 16 60 6 24 7 39 57 30
2021/2022544 2 73 5 19 32 4 26 17 3 120 76 167
2022/20231.563 134 169 75 144 124 152 9 94 609 7 31 15
2023/2024326 31 50 14 32 27 98 2 21 0 14 5 32
2024/20251.151 24 14 53 99 43 62 35 296 393 120 12 0
Totale 4.827